Exposure to hydrogen peroxide diminishes NF-κB activation, IκB-α degradation, and proteasome activity in neutrophils

American Journal of Physiology - Cell Physiology

Volumn 293, Issue 1, 2007, Pages

  Zmijewski, Jaroslaw W ^a,b   Zhao, Xia ^a   Xu, Zhiwei ^a   Abraham, Edward ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Nuclear factor B; Reactive oxygen species; Signal transduction

Indexed keywords

CHYMOTRYPSIN; HYDROGEN PEROXIDE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; MACROPHAGE MIGRATION INHIBITION FACTOR; PROTEASOME; TRYPSIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; BONE MARROW; CELL CULTURE; CELL POPULATION; CELL SPECIFICITY; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; EXPOSURE; LEUKOCYTE ACTIVATION; MACROPHAGE; MACROPHAGE ACTIVATION; MOUSE; NEUTROPHIL; NONHUMAN; NUCLEAR IMPORT; PERITONEUM; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TRANSPORT;

ACTIVE TRANSPORT, CELL NUCLEUS; ANIMALS; CELL NUCLEUS; CELLS, CULTURED; CHEMOKINES; CHYMOTRYPSIN; DOSE-RESPONSE RELATIONSHIP, DRUG; HYDROGEN PEROXIDE; I-KAPPA B PROTEINS; LIPOPOLYSACCHARIDES; MACROPHAGES, ALVEOLAR; MALE; MICE; MICE, INBRED BALB C; NEUTROPHILS; NF-KAPPA B; PROTEASOME ENDOPEPTIDASE COMPLEX; SERINE PROTEINASE INHIBITORS; TIME FACTORS; TRYPSIN; TRYPSIN INHIBITORS; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE;

EID: 34547137901     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00618.2006     Document Type: Article

References (61)

1. Abraham E. Neutrophils and acute lung injury. Crit Care Med 31: S195-199, 2003.
2. Abraham E. Nuclear factor-kappaB and its role in sepsis-associated organ failure. J Infect Dis 187, Suppl 2: S364-S369, 2003.
3. Alkalay I, Yaron A, Hatzubai A, Jung S, Avraham A, Gerlitz O, Pashut-Lavon I, Ben-Neriah Y. In vivo stimulation of I kappa B phosphorylation is not sufficient to activate NF-kappaB. Mol Cell Biol 15: 1294-1301, 1995.
4. Alkalay I, Yaron A, Hatzubai A, Orian A, Ciechanover A, Ben-Neriah Y. Stimulation-dependent IkappaBalpha phosphorylation marks the NF-kappaB inhibitor for degradation via the ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 92: 10599-10603, 1995.
5. Atkinson MC. The use of N-acetylcysteine in intensive care. Crit Care Resusc 4: 21-27, 2002.
6. Ben-Neriah Y. Regulatory functions of ubiquitination in the immune system. Nat Immun 3: 20-26, 2002.
7. Bence NF, Sampat RM, Kopito RR. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 292: 1552-1555, 2001.
8. Berg K, Wiseth R, Bjerve K, Brurok H, Gunnes S, Skarra S, Jynge P, Basu S. Oxidative stress and myocardial damage during elective percutaneous coronary interventions and coronary angiography. A comparison of blood-borne isoprostane and troponin release. Free Radic Res 38: 517-525, 2004.
9. Bonizzi G, Piette J, Schoonbroodt S, Greimers R, Havard L, Merville MP, Bours V. Reactive oxygen intermediate-dependent NF-kappaB activation by interleukin-1beta requires 5-lipoxygenase or NADPH oxidase activity. Mol Cell Biol 19: 1950-1960, 1999.
10. Brennan P, O'Neill LA. Effects of oxidants and antioxidants on nuclear factor kappaB activation in three different cell lines: evidence against a universal hypothesis involving oxygen radicals. Biochim Biophys Acta 1260: 167-175, 1995.
11. Brown KA, Brain SD, Pearson JD, Edgeworth JD, Lewis SM, Treacher DF. Neutrophils in development of multiple organ failure in sepsis. Lancet 368: 157-169, 2006.
12. Canty TG Jr, Boyle EM Jr, Farr A, Morgan EN, Verrier ED, Pohlman TH. Oxidative stress induces NF-kappaB nuclear translocation without degradation of IkappaBalpha. Circulation 100: II361-II364, 1999.
13. Cepkova M, Matthay MA. Pharmacotherapy of acute lung injury and the acute respiratory distress syndrome. J Intensive Care Med 21: 119-143, 2006.
14. Chen ZJ. Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol 7: 758-765, 2005.
15. Cowley HC, Bacon PJ, Goode HF, Webster NR, Jones JG, Menon DK. Plasma antioxidant potential in severe sepsis: a comparison of survivors and nonsurvivors. Crit Care Med 24: 1179-1183, 1996.
16. Davies KJ. Degradation of oxidized proteins by the 20S proteasome. Biochimie 83: 301-310, 2001.
17. Ding Q, Lewis JJ, Strum KM, Dimayuga E, Bruce-Keller AJ, Dunn JC, Keller JN. Polyglutamine expansion, protein aggregation, proteasome activity, and neural survival. J Biol Chem 277: 13935-13942, 2002.
18. Doyle SL, O'Neill LA. Toll-like receptors: from the discovery of NFkappaB to new insights into transcriptional regulations in innate immunity. Biochem Pharmacol 72: 1102-1113, 2006.
19. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82: 47-95, 2002.
20. Forman HJ, Torres M. Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am J Respir Crit Care Med 166: S4-8, 2002.
21. Fujihara SM, Cleaveland JS, Grosmaire LS, Berry KK, Kennedy KA, Blake JJ, Loy J, Rankin BM, Ledbetter JA, Nadler SG. A D-amino acid peptide inhibitor of NF-kappa B nuclear localization is efficacious in models of inflammatory disease. J Immunol 165: 1004-1012, 2000.
22. Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell 109, Suppl: S81-S96, 2002.
23. Hyslop PA, Hinshaw DB, Halsey WA Jr, Schraufstatter IU, Sauerheber RD, Spragg RG, Jackson JH, Cochrane CG. Mechanisms of oxidant-mediated cell injury. The glycolytic and mitochondrial pathways of ADP phosphorylation are major intracellular targets inactivated by hydrogen peroxide. J Biol Chem 263: 1665-1675, 1988.
24. Jaspers I, Zhang W, Fraser A, Samet JM, Reed W. Hydrogen peroxide has opposing effects on IKK activity and IkappaBalpha breakdown in airway epithelial cells. Am J Respir Cell Mol Biol 24: 769-777, 2001.
25. Jiang ZY, Hunt JV, Wolff SP. Ferrous ion oxidation in the presence of xylenol orange for detection of lipid hydroperoxide in low density lipoprotein. Anal Biochem 202: 384-389, 1992.
26. Khadaroo RG, Kapus A, Powers KA, Cybulsky MI, Marshall JC, Rotstein OD. Oxidative stress reprograms lipopolysaccharide signaling via Src kinase-dependent pathway in RAW 264.7 macrophage cell line. J Biol Chem 278: 47834-47841, 2003.
27. Kleinert H, Pautz A, Linker K, Schwarz PM. Regulation of the expression of inducible nitric oxide synthase. Eur J Pharmacol 500: 255-266, 2004.
28. Korn SH, Wouters EF, Vos N, Janssen-Heininger YM Cytokine-induced activation of nuclear factor-kappa B is inhibited by hydrogen peroxide through oxidative inactivation of IkappaB kinase. J Biol Chem 276: 35693-35700, 2001.
29. Kostikas K, Papatheodorou G, Psathakis K, Panagou P, Loukides S. Oxidative stress in expired breath condensate of patients with COPD. Chest 124: 1373-1380, 2003.
30. Kotamraju S, Kalivendi S, Shang T, Kalyanaraman B. Nitric oxide, proteasomal function, and iron homeostasis-implications in aging and neurodegenerative diseases. Methods Enzymol 396: 526-534, 2005.
31. 2-induced transferrin receptor-dependent apoptosis in endothelial cells: role of ubiquitin-proteasome pathway. Proc Natl Acad Sci USA 100: 10653-10658, 2003.
32. Krappmann D, Scheidereit C. A pervasive role of ubiquitin conjugation in activation and termination of IkappaB kinase pathways. EMBO Rep 6: 321-326, 2005.
33. Lekstrom-Himes JA, Kuhns DB, Alvord WG, Gallin JI. Inhibition of human neutrophil IL-8 production by hydrogen peroxide and dysregulation in chronic granulomatous disease. J Immunol 174: 411-417, 2005.
34. Letoha T, Somlai C, Takacs T, Szabolcs A, Rakonczay Z Jr, Jarmay K, Szalontai T, Varga I, Kaszaki J, Boros I, Duda E, Hackler L, Kurucz I, Penke B. The proteasome inhibitor MG132 protects against acute pancreatitis. Free Radic Biol Med 39: 1142-1151, 2005.
35. Lu Y, Wahl LM. Oxidative stress augments the production of matrix metalloproteinase-1, cyclooxygenase-2, and prostaglandin E2 through enhancement of NF-kappa B activity in lipopolysaccharide-activated human primary monocytes. J Immunol 175: 5423-5429, 2005.
36. Matthews JR, Wakasugi N, Virelizier JL, Yodoi J, Hay RT. Thioredoxin regulates the DNA binding activity of NF-kappa B by reduction of a disulphide bond involving cysteine 62. Nucleic Acids Res 20: 3821-3830, 1992.
37. Mitra S, Abraham E. Participation of superoxide in neutrophil activation and cytokine production. Biochim Biophys Acta 1762: 732-741, 2006.
38. Molnar Z, Shearer E, Lowe D. N-acetylcysteine treatment to prevent the progression of multisystem organ failure: a prospective, randomized, placebo-controlled study. Crit Care Med 27: 1100-1104, 1999.
39. 2 release from intact peroxisomes. Biochem J 363: 483-491, 2002.
40. Nam S, Smith DM, Dou QP. Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J Biol Chem 276: 13322-13330, 2001.
41. Nishi T, Shimizu N, Hiramoto M, Sato I, Yamaguchi Y, Hasegawa M, Aizawa S, Tanaka H, Kataoka K, Watanabe H, Handa H. Spatial redox regulation of a critical cysteine residue of NF-kappa B in vivo. J Biol Chem 277: 44548-44556, 2002.
42. O'Neill LA. Signal transduction pathways activated by the IL-1 receptor/toll-like receptor superfamily. Curr Top Microbiol Immunol 270: 47-61, 2002.
43. Pajonk F, Riess K, Sommer A, McBride WH. N-acetyl- L-cysteine inhibits 26S proteasome function: implications for effects on NF-kappaB activation. Free Radic Biol Med 32: 536-543, 2002.
44. Rahman I, Biswas SK, Jimenez LA, Torres M, Forman HJ. Glutathione, stress responses, and redox signaling in lung inflammation. Antioxid Redox Signal 7: 42-59, 2005.
45. Reinheckel T, Sitte N, Ullrich O, Kuckelkorn U, Davies KJ, Grune T. Comparative resistance of the 20S and 26S proteasome to oxidative stress. Biochem J 335: 637-642, 1998.
46. Reinheckel T, Ullrich O, Sitte N, Grune T. Differential impairment of 20S and 26S proteasome activities in human hematopoietic K562 cells during oxidative stress. Arch Biochem Biophys 377: 65-68, 2000.
47. Rhee SG, Bae YS, Lee SR, Kwon J. Hydrogen peroxide: a key messenger that modulates protein phosphorylation through cysteine oxidation. Sci STKE: PE1, 2000.
48. Scherer DC, Brockman JA, Chen Z, Maniatis T, Ballard DW. Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination. Proc Natl Acad Sci USA 92: 11259-11263, 1995.
49. Schreck R, Albermann K, Baeuerle PA. Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). Free Radic Res Commun 17: 221-237, 1992.
50. Sporn PH, Peters-Golden M. Hydrogen peroxide inhibits alveolar macrophage 5-lipoxygenase metabolism in association with depletion of ATP. J Biol Chem 263: 14776-14783, 1988.
51. 2: disparate effects on kinases, NF-κB, and cytokine expression. Am J Physiol Cell Physiol 286: C683-C692, 2004.
52. Tabata M, Tabata R, Grabowski DR, Bukowski RM, Ganapathi MK, Ganapathi R. Roles of NF-kappaB and 26 S proteasome in apoptotic cell death induced by topoisomerase I and II poisons in human nonsmall cell lung carcinoma. J Biol Chem 276: 8029-8036, 2001.
53. Takeuchi O, Akira S. Toll-like receptors; their physiological role and signal transduction system. Int Immunopharmacol 1: 625-635, 2001.
54. Taqueti VR, Mitchell RN, Lichtman AH. Protecting the pump: controlling myocardial inflammatory responses. Annu Rev Physiol 68: 67-95, 2006.
55. Torrie LJ, MacKenzie CJ, Paul A, Plevin R. Hydrogen peroxide-mediated inhibition of lipopolysaccharide-stimulated inhibitory kappa B kinase activity in rat aortic smooth muscle cells. Br J Pharmacol 134: 393-401, 2001.
56. 2 and TNF-α and its effects on ICAM-1 expression in endothelial cells. Am J Physiol Lung Cell Mol Physiol 279: L302-L311, 2000.
57. Watanabe N, Zmijewski JW, Takabe W, Umezu-Goto M, Le Goffe C, Sekine A, Landar A, Watanabe A, Aoki J, Arai H, Kodama T, Murphy MP, Kalyanaraman R, Darley-Usmar VM, Noguchi N. Activation of mitogen-activated protein kinases by lysophosphatidylcholine-induced mitochondrial reactive oxygen species generation in endothelial cells. Am J Pathol 168: 1737-1748, 2006.
58. Yum HK, Arcaroli J, Kupfner J, Shenkar R, Penninger JM, Sasaki T, Yang KY, Park JS, Abraham E. Involvement of phosphoinositide 3-kinases in neutrophil activation and the development of acute lung injury. J Immunol 167: 6601-6608, 2001.
59. Zhang G, Ghosh S. Molecular mechanisms of NF-kappaB activation induced by bacterial lipopolysaccharide through Toll-like receptors. J Endotoxin Res 6: 453-457, 2000.
60. Zmijewski JW, Landar A, Watanabe N, Dickinson DA, Noguchi N, Darley-Usmar VM. Cell signalling by oxidized lipids and the role of reactive oxygen species in the endothelium. Biochem Soc Trans 33: 1385-1389, 2005.
61. Zmijewski JW, Moellering DR, Le Goffe C, Landar A, Ramachandran A, Darley-Usmar VM. Oxidized LDL induces mitochondrially associated reactive oxygen/nitrogen species formation in endothelial cells. Am J Physiol Heart Circ Physiol 289: H852-H861, 2005.